One-time gene editing treatment lowers 'bad' cholesterol by up to 62%

medicalxpress - Patients in London have received a pioneering new gene editing therapy that lowers "bad" cholesterol after a single infusion, as part of a study involving UCL scientists.

AI Summary: Early clinical data show a one‑time gene‑editing infusion can reduce LDL cholesterol by as much as 62% in patients with severe hypercholesterolemia. The approach, still experimental, produced large lipid drops with early safety signals, hinting at a possible future one‑and‑done therapy for high‑risk cardiovascular patients — pending larger trials and careful long‑term follow‑up.

---

Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61

Related Stories

---

Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

Gene therapy restores hearing in about 90% of trial participants / 5 wks

Stem cells show potent promise as a diabetes treatment / 8 days

FDA clears AstraZeneca’s new blood-pressure drug baxdrostat / 13 days

Antiviral ensitrelvir dramatically cuts household COVID transmission risk / 16 days

Gene therapy pioneers win Breakthrough Prize for CRISPR sickle‑cell work / 6 wks

First‑in‑human CRISPR/Cas12a sickle cell therapy treated; gene editing shows promise / 1 month

Denali drug receives accelerated approval for rare CNS indication / 2 months